PARANEOPLASTIC SYNDROME side effect
What is PARANEOPLASTIC SYNDROME ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
PARANEOPLASTIC SYNDROME and Recently Reported Side Effects
PARANEOPLASTIC SYNDROME and 15 most Active Side Effect polls
PARANEOPLASTIC SYNDROME and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with PARANEOPLASTIC SYNDROME
BEVACIZUMAB BISOPROLOL CILOSTAZOL FASLODEX FEMARA FLUOROURACIL FUZEON GEMZAR LARIAM LEUPROLIDE LEVOFLOXACIN MABTHERA MAGNEVIST REMICADE XYLOCAINEBevacizumab Side Effects Report #5551383-0
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Dec 04, 2007. Male patient, weighting 159.0 lb, was diagnosed with colorectal cancer metastatic, colon cancer metastatic, atrial fibrillation, hypertension, dyspepsia and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: paraneoplastic syndrome, . BEVACIZUMAB dosage: 385.5 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, COUMADIN, COZAAR, CARDIZEM, PEPCID. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5475899-0
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Sept 21, 2007. Male patient, weighting 159.0 lb, was diagnosed with colorectal cancer metastatic, colon cancer metastatic, atrial fibrillation, hypertension, dyspepsia and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: paraneoplastic syndrome, . BEVACIZUMAB dosage: 385.5 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN, COUMADIN, COZAAR, CARDIZEM, PEPCID. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5443545-8
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Aug 27, 2007. Male patient, weighting 159.0 lb, was diagnosed with colorectal cancer metastatic, atrial fibrillation, hypertension, dyspepsia and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: paraneoplastic syndrome, . BEVACIZUMAB dosage: 385.5 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, COUMADIN, COZAAR, CARDIZEM, PEPCID. Patient died on 07/31/2007.
Bevacizumab Side Effects Report #5444014-1
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Aug 28, 2007. Male patient was diagnosed with colorectal cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: paraneoplastic syndrome, sepsis, . BEVACIZUMAB dosage: 1385.5 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, FOLINIC ACID, COUMADIN, COZAAR, CARDIZEM, PEPCID. Patient was hospitalized. Patient died on 07/31/2007.
Bevacizumab Side Effects Report #5467474-9
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Sept 14, 2007. Male patient, weighting 159.0 lb, was diagnosed with colorectal cancer metastatic, atrial fibrillation, hypertension, dyspepsia and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: paraneoplastic syndrome, sepsis, . BEVACIZUMAB dosage: 385.5 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN, COUMADIN, COZAAR, CARDIZEM, PEPCID. Patient died on 07/31/2007.
Bevacizumab Side Effects Report #5413586-5
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Aug 06, 2007. Male patient, weighting 159.0 lb, was diagnosed with colorectal cancer metastatic, atrial fibrillation, hypertension, dyspepsia and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: paraneoplastic syndrome, sepsis, . BEVACIZUMAB dosage: 385.5 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, COUMADIN, COZAAR, CARDIZEM, PEPCID. Patient died on 07/31/2007.
Bevacizumab Side Effects Report #5420845-9
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Aug 10, 2007. Male patient, weighting 159.0 lb, was diagnosed with colorectal cancer metastatic, atrial fibrillation, hypertension, dyspepsia and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: paraneoplastic syndrome, . BEVACIZUMAB dosage: 385.5 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, COUMADIN, COZAAR, CARDIZEM, PEPCID. Patient died on 07/31/2007.
Gemzar Side Effects Report #5319980-5
GEMZAR problem was reported by a Physician from UNITED STATES on May 04, 2007. Female patient, 68 years of age, was diagnosed with ovarian cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: paraneoplastic syndrome, . GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.
Faslodex Side Effects Report #5283515-6
Health Professional from ITALY reported FASLODEX problem on Mar 29, 2007. Female patient, 70 years of age, was diagnosed with breast cancer metastatic and was treated with FASLODEX. After drug was administered, patient experienced the following problems/side effects: paraneoplastic syndrome, . FASLODEX dosage: unknown. During the same period patient was treated with CAPECITABINE. Patient recovered.
Faslodex Side Effects Report #5262672-1
FASLODEX problem was reported by a Health Professional from ITALY on Mar 01, 2007. Female patient, 70 years of age, was diagnosed with breast cancer metastatic and was treated with FASLODEX. After drug was administered, patient experienced the following problems/side effects: paraneoplastic syndrome, . FASLODEX dosage: unknown. Patient recovered.
Faslodex Side Effects Report #5281695-X
Health Professional from ITALY reported FASLODEX problem on Mar 29, 2007. Female patient, 70 years of age, was diagnosed with breast cancer metastatic and was treated with FASLODEX. After drug was administered, patient experienced the following problems/side effects: paraneoplastic syndrome, . FASLODEX dosage: unknown. During the same period patient was treated with CAPECITABINE. Patient recovered.
Xylocaine Side Effects Report #5612550-0
XYLOCAINE problem was reported by a Health Professional from FRANCE on Jan 31, 2008. Male patient, 79 years of age, was diagnosed with lung disorder, ischaemic cardiomyopathy and was treated with XYLOCAINE. After drug was administered, patient experienced the following problems/side effects: dermatitis bullous, paraneoplastic syndrome, rash macular, serratia infection, skin exfoliation, . XYLOCAINE dosage: unknown. During the same period patient was treated with CARBOCAINE, DIPRIVAN, PROFENID, PERFALGAN, AUGMENTIN, CIFLOX, OFLOCET, LASILIX. Patient was hospitalized. Patient recovered.
Leuprolide Side Effects Report #5569743-0
Consumer or non-health professional from AUSTRIA reported LEUPROLIDE ACETATE problem on Dec 14, 2007. Male patient, 73 years of age, was diagnosed with neoplasm prostate and was treated with LEUPROLIDE ACETATE. After drug was administered, patient experienced the following problems/side effects: cushing's syndrome, paraneoplastic syndrome, . LEUPROLIDE ACETATE dosage: 11.25 MG (11.25 MG, 1 IN 3 M) SUBCUTANEOUS. During the same period patient was treated with BISOPROLOL, MARCUMAR, DEFLAMAT, ZOMETA. Patient was hospitalized. Patient recovered.
Femara Side Effects Report #5465852-5
FEMARA problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 13, 2007. Female patient was diagnosed with breast cancer and was treated with FEMARA. After drug was administered, patient experienced the following problems/side effects: erythema, paraneoplastic syndrome, polyarthritis, swelling, . FEMARA dosage: 2.5 MG, QD. Patient was hospitalized. Patient recovered.
Lariam Side Effects Report #5382114-5
Health Professional from UNITED STATES reported LARIAM problem on June 27, 2007. Female patient, 51 years of age, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: amyotrophic lateral sclerosis, paraneoplastic syndrome, . LARIAM dosage: unknown. During the same period patient was treated with RILUTEK, VITAMIN E, ASCORBIC ACID, VITAMINS NOS, COENZYME Q, ALPHA LIPOIC ACID. Patient was hospitalized. Patient recovered.
Cilostazol Side Effects Report #5403551-6
CILOSTAZOL problem was reported by a Consumer or non-health professional from JAPAN on July 17, 2007. Male patient, 74 years of age, was diagnosed with shunt occlusion and was treated with CILOSTAZOL. After drug was administered, patient experienced the following problems/side effects: megakaryocytes decreased, paraneoplastic syndrome, platelet count decreased, pleural effusion, . CILOSTAZOL dosage: 100 MG. During the same period patient was treated with SEVELAMER HYDROCHLORIDE, PRECIPITATED CALCIUM CARBONATE, HAEMODIALYSIS. Patient recovered.
Lariam Side Effects Report #5382114-5
Health Professional from UNITED STATES reported LARIAM problem on June 27, 2007. Female patient, 51 years of age, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: amyotrophic lateral sclerosis, paraneoplastic syndrome, . LARIAM dosage: unknown. During the same period patient was treated with RILUTEK, VITAMIN E, ASCORBIC ACID, VITAMINS NOS, COENZYME Q, ALPHA LIPOIC ACID. Patient was hospitalized. Patient recovered.
Cilostazol Side Effects Report #5403551-6
CILOSTAZOL problem was reported by a Consumer or non-health professional from JAPAN on July 17, 2007. Male patient, 74 years of age, was diagnosed with shunt occlusion and was treated with CILOSTAZOL. After drug was administered, patient experienced the following problems/side effects: megakaryocytes decreased, paraneoplastic syndrome, platelet count decreased, pleural effusion, . CILOSTAZOL dosage: 100 MG. During the same period patient was treated with SEVELAMER HYDROCHLORIDE, PRECIPITATED CALCIUM CARBONATE, HAEMODIALYSIS. Patient recovered.
Mabthera Side Effects Report #5744698-4
Physician from UNITED KINGDOM reported MABTHERA problem on May 08, 2008. Male patient, 30 years of age, was diagnosed with non-hodgkin's lymphoma, prophylaxis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: brain injury, paraneoplastic syndrome, pneumonia, tremor, urinary tract infection, . MABTHERA dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE, ANALGESIC, CEPHALEXIN. Patient was hospitalized. Patient recovered.
Lariam Side Effects Report #5369184-5
LARIAM problem was reported by a Health Professional from UNITED STATES on June 15, 2007. Female patient, 51 years of age, was diagnosed with malaria prophylaxis and was treated with LARIAM. After drug was administered, patient experienced the following problems/side effects: amyotrophic lateral sclerosis, paraneoplastic syndrome, . LARIAM dosage: unknown. During the same period patient was treated with RILUTEK, VITAMIN E, ASCORBIC ACID, VITAMINS NOS, COENZYME Q, ALPHA LIPOIC ACID. Patient was hospitalized. Patient recovered.
Fuzeon Side Effects Report #5326474-X
Health Professional from UNITED STATES reported FUZEON problem on May 08, 2007. Female patient, 74 years of age, weighting 132.1 lb, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: eaton-lambert syndrome, paraneoplastic syndrome, . FUZEON dosage: unknown. During the same period patient was treated with APTIVUS, NORVIR, VIREAD, ZERIT, VIDEX, PROCARDIA, LASIX. Patient was hospitalized. Patient recovered.
Magnevist Side Effects Report #5304947-3
MAGNEVIST problem was reported by a Physician from FRANCE on Apr 16, 2007. Male patient, 52 years of age, weighting 176.4 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: metastases to lung, paraneoplastic syndrome, . MAGNEVIST dosage: unknown. Patient recovered.
Remicade Side Effects Report #5310469-6
Physician from UNITED STATES reported REMICADE problem on Apr 19, 2007. Female patient, weighting 112.0 lb, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: lymphoma, paraneoplastic syndrome, . REMICADE dosage: unknown. During the same period patient was treated with METHOTREXATE, ULTRACET. Patient was hospitalized. Patient recovered.
Remicade Side Effects Report #5281320-8
REMICADE problem was reported by a Physician from UNITED STATES on Mar 21, 2007. Female patient, weighting 112.0 lb, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: lymphoma, paraneoplastic syndrome, . REMICADE dosage: unknown. During the same period patient was treated with METHOTREXATE, ULTRACET. Patient was hospitalized. Patient recovered.
Bisoprolol Side Effects Report #5284313-X
Consumer or non-health professional from FRANCE reported BISOPROLOL FUMARATE problem on Mar 19, 2007. Male patient, 80 years of age, was treated with BISOPROLOL FUMARATE. After drug was administered, patient experienced the following problems/side effects: paraneoplastic syndrome, retroperitoneal fibrosis, . BISOPROLOL FUMARATE dosage: unknown. During the same period patient was treated with EBIXA, NOVONORM, MOPRAL, DIGOXIN, METFORMIN, FUROSEMIDE, COZAAR, PREVISCAN. Patient died.
Fluorouracil Side Effects Report #5425848-6
FLUOROURACIL problem was reported by a Health Professional from UNITED STATES on Aug 13, 2007. Male patient, 82 years of age, was diagnosed with colorectal cancer metastatic and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: anaemia, dehydration, paraneoplastic syndrome, sepsis, stomatitis, . FLUOROURACIL dosage: 1800 MILLIGRAM/SQ. METER 2 WEEK, INTRAVENOUS DRIP. During the same period patient was treated with FOLINIC ACID, OXALIPLATIN, BEVACIZUMAB, WARFARIN, LOSARTAN POTASSIUM, DILTIAZEM, FAMOTIDINE, DIGOXIN. Patient was hospitalized. Patient died on 07/31/2007.
Bevacizumab Side Effects Report #5341574-6
Pharmacist from UNITED STATES reported BEVACIZUMAB problem on May 29, 2007. Male patient, weighting 175.0 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cognitive disorder, encephalitis, paraneoplastic syndrome, . BEVACIZUMAB dosage: 750 MG Q 4 WKS IV. During the same period patient was treated with ZOMETA, ARIXTRA. Patient recovered.
Levofloxacin Side Effects Report #5258316-5
LEVOFLOXACIN problem was reported by a Physician from JAPAN on Feb 27, 2007. Male patient, 59 years of age, was treated with LEVOFLOXACIN. After drug was administered, patient experienced the following problems/side effects: erythema, neuroblastoma, paraneoplastic syndrome, . LEVOFLOXACIN dosage: unknown. During the same period patient was treated with DEPAKENE, LINTON, HARNAL D, MAGMITT. Patient was hospitalized. Patient recovered.